WAVE Life Sciences Enters Partnership with Pfizer to Develop Genetically Targeted Therapies for the Treatment of Metabolic Diseases, Pfizer To Pay $40M Upfront With $30 As Equity Inv. In Wave At $16/Share; Potential For $871M Through Milestones